Role of Endobronchial Navigation in Lung Cancer Management
Open Access
- 15 September 2025
- book chapter
- Published by IntechOpen
Abstract
The landscape of lung cancer management is undergoing a transformative paradigm shift, shifting from the traditional focus on solitary tumors to the recognition and treatment of small, multifocal, ground-glass lesions—a change driven predominantly by the widespread adoption of low-dose computed tomography screening. These multifocal tumors pose unprecedented diagnostic and therapeutic challenges due to their minute size, often subsolid consistency, and complex distribution within the lung. To address these complexities, pioneering technological innovations have emerged to enhance lesion localization accuracy and elevate treatment precision. Among these, the advent of advanced navigation bronchoscopy stands out as a groundbreaking development, revolutionizing both diagnostic workflows and local ablation strategies, thereby fundamentally redefining the management of multifocal lung tumors. This approach has yielded remarkable clinical outcomes, characterized by superior efficacy and a highly favorable safety profile. Further elevating this field are integrations of robotic-assisted bronchoscopy, hybrid operating room, and artificial intelligence—collectively constituting a comprehensive, streamlined treatment pathway that aims to deliver a cohesive, minimally invasive, one-stop solution for lung cancer therapy. As these technologies continue to evolve, an array of innovative bronchoscopy systems and ablative modalities remain at the forefront of ongoing research and development. In this chapter, we will explore the transformative role of navigation bronchoscopy in lung cancer management, critically examine the latest technological breakthroughs, and project future directions poised to redefine therapeutic standards in this rapidly evolving domain.Keywords
This publication has 159 references indexed in Scilit:
- Safety and Feasibility of Pulsed Electric Field Ablation for Early‐Stage Non‐Small Cell Lung Cancer Prior to Surgical ResectionJournal of Surgical Oncology, 2025
- Lung cancer statistics, 2023Cancer, 2024
- Management of locally advanced non‐small cell lung cancer: State of the art and future directionsCancer Communications, 2023
- Clinical and Dosimetric Risk Factors Associated With Radiation-Induced Lung Toxicities After Multiple Courses of Lung Stereotactic Body Radiation TherapyAdvances in Radiation Oncology, 2023
- Treatment of Post-Ablation Bronchopleural Fistula Using Percutaneous Synthetic Hydrogel Surgical Sealant: Initial Experience of Safety and EfficacyCardioVascular and Interventional Radiology, 2020
- Efficiency of thoracoscopic palpation in localizing small pulmonary nodulesSurgery Today, 2019
- Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung CancerJAMA Network Open, 2018
- Complication rates of CT-guided transthoracic lung biopsy: meta-analysisEuropean Radiology, 2016
- Radiofrequency ablation of stage IA non–small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trialCancer, 2015
- Accuracy of CT-guided transthoracic needle biopsy of lung lesions: Factors affecting diagnostic yieldLa radiologia medica, 2007